| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/IUB.1614 |
| P698 | PubMed publication ID | 28276155 |
| P50 | author | Jennifer Lowe | Q59221101 |
| P2093 | author name string | Elaine Hilário-Souza | |
| Rosilane Taveira-da-Silva | |||
| P2860 | cites work | Diabetes and dietary copper alter 67Cu metabolism and oxidant defense in the rat. | Q46159755 |
| Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in | Q46458763 | ||
| A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. | Q46476987 | ||
| Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation | Q46907928 | ||
| The chemical biology of copper. | Q47829431 | ||
| Whole animal copper flux assessed by positron emission tomography in the Long-Evans cinnamon rat--a feasibility study. | Q53586072 | ||
| Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism. | Q54427344 | ||
| Copper-mediated formation of hydrogen peroxide from the amylin peptide: A novel mechanism for degeneration of islet cells in type-2 diabetes mellitus? | Q58414922 | ||
| Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus | Q84206643 | ||
| Oxidative stress as a major culprit in kidney disease in diabetes | Q28281957 | ||
| Oxygen toxicity, oxygen radicals, transition metals and disease | Q29615096 | ||
| The role of oxidative stress and NF-kappaB activation in late diabetic complications | Q33803284 | ||
| Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation | Q33804265 | ||
| Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications | Q35766899 | ||
| Cellular responses to the metal-binding properties of metformin. | Q35976604 | ||
| Copper, zinc, and magnesium levels in non-insulin dependent diabetes mellitus | Q36728371 | ||
| Function and regulation of human copper-transporting ATPases | Q36872228 | ||
| The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: therapeutic effects by chelators | Q37084732 | ||
| Copper transporter ATP7A protects against endothelial dysfunction in type 1 diabetic mice by regulating extracellular superoxide dismutase | Q37251149 | ||
| New developments in the regulation of intestinal copper absorption | Q37631160 | ||
| Management of cardiorenal metabolic syndrome in diabetes mellitus: a phytotherapeutic perspective | Q37730653 | ||
| Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases | Q37838281 | ||
| Diabetic retinopathy: loss of neuroretinal adaptation to the diabetic metabolic environment | Q38199730 | ||
| The promise of copper lowering therapy with tetrathiomolybdate in the cure of cancer and in the treatment of inflammatory disease | Q38246566 | ||
| EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes | Q38585738 | ||
| Animal models of insulin resistance: A review | Q38957579 | ||
| Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells. | Q40207771 | ||
| A study of cupremia in a group of elderly diabetics. | Q41606441 | ||
| Cellular Trace Element Changes in Type 1 Diabetes Patients | Q41676831 | ||
| Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents | Q41679218 | ||
| Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: Evidence for increased oxidative stress as a variable complication | Q41679402 | ||
| Penicillamine-induced rapidly progressive glomerulonephritis in a patient with rheumatoid arthritis. | Q42287001 | ||
| Copper and ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. | Q42327724 | ||
| Modulation of hepatic copper-ATPase activity by insulin and glucagon involves protein kinase A (PKA) signaling pathway | Q42497719 | ||
| Dietary copper supplementation restores β-cell function of Cohen diabetic rats: a link between mitochondrial function and glucose-stimulated insulin secretion | Q42712392 | ||
| Reversal of diabetes-evoked changes in mitochondrial protein expression of cardiac left ventricle by treatment with a copper(II)-selective chelator | Q42784912 | ||
| Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. | Q43134093 | ||
| Influence of therapy with metformin on the concentration of certain divalent cations in patients with non-insulin-dependent diabetes mellitus | Q43975653 | ||
| Assessment of DNA base oxidation and glutathione level in patients with type 2 diabetes. | Q44100506 | ||
| Elemental contents in serum of pregnant women with gestational diabetes mellitus | Q44150276 | ||
| Regeneration of the heart in diabetes by selective copper chelation | Q45032429 | ||
| Oxidative stress and antioxidant defense in relation to the severity of diabetic polyneuropathy and cardiovascular autonomic neuropathy | Q45034117 | ||
| Magnesium, zinc and copper in plasma and blood cellular components in children with IDDM. | Q45094913 | ||
| Association of serum copper levels and glycemic control in patients with type 2 diabetes | Q45731663 | ||
| Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. | Q45919166 | ||
| Role of copper ion in the pathogenesis of type 2 diabetes. | Q46001596 | ||
| Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications | Q46158575 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 255-262 | |
| P577 | publication date | 2017-03-09 | |
| P1433 | published in | IUBMB Life | Q15764029 |
| P1476 | title | Dissecting copper homeostasis in diabetes mellitus | |
| P478 | volume | 69 |
| Q52672954 | Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma. |
| Q89633274 | Current Biomedical Use of Copper Chelation Therapy |
| Q60308358 | Serum trace elements in insulin-dependent and non-insulin-dependent diabetes: a comparative study |
| Q92856268 | Silver Ions as a Tool for Understanding Different Aspects of Copper Metabolism |
| Q90331738 | The Influence of Taurine Supplementation on Serum and Tissular Fe, Zn and Cu Levels in Normal and Diet-Induced Insulin-Resistant Rats |
Search more.